BioSentinel SmallSat 2022 Presentation

Matthew Napoli

NASA NTRS · 20220010766

BioSentinel SmallSat 2022 Presentation

Abstract

BioSentinel, an Artemis-1 secondary spacecraft, will carry a biology experiment into deep space for the first time in 50 years. A 6U CubeSat form factor was utilized for the spacecraft and included technologies newly developed or adapted for operations beyond Earth orbit. This is the maiden deep-space voyage for the radio, propulsion system, electrical power system, and BioSensor payload. The spacecraft carries onboard budding yeast, Saccharomyces cerevisiae, as an analog to human cells to test the biological response to deep space radiation.

Explore related subjects

BioSentinel Deep space CubeSat Artemis-1

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

Matthew Napoli. BioSentinel SmallSat 2022 Presentation. https://ntrs.nasa.gov/citations/20220010766

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related reports

NASA NTRS2024

Flight Dynamics and Navigation Performance of the BioSentinel Mission

BioSentinel was one of ten CubeSats launched by the Space Launch System (SLS) as part of the Artemis I campaign on 16 November 2022. A lunar flyby gave BioSentinel the needed energy to escape the Earth-Moon system into heliocentric space. The biological payload contains yeast cells designed to measure radiation in deep space beyond the reach of Earth’s magnetosphere. This paper discusses in detail the BioSentinel flight performance, as well as challenges and lessons learned prior to, and during the mission.

BioSentinel↗

NASA NTRS2022

BioSentinel: Build your own BioSentinel Model!

BioSentinel will conduct the first study of the biological response to space radiation outside LEO since the Apollo missions. The project will investigate the biological effects of space radiation, and will provide an adaptable platform to perform human relevant measurements in multiple space environments in the future, including on lunar and Mars landers and orbiters.

BioSentinel↗

NASA NTRS2020

BioSentinel ISS Control Experiment Final Investigation Summary Form

Each payload has 18 fluidic cards and each fluidic card has 16 microfluidic wells, for a total of 288 wells. Card activation occurs at different time points throughout the 6-month mission and following ground commands. At each timepoint, two fluidic cards are filled with growth medium containing nutrients and a metabolic indicator dye. In addition to card filling, the temperature of the cards increases from ~4°C (stasis mode) to 23°C to allow for cell growth. The metabolic dye changes color from blue to pink, then pink to clearin the presence of metabolically active yeast cells. The colorimetric changes and cell growth are monitored using a 3-light-emitting diode(LED)optical detection system. The optical data determines how fast the cells are able to recover after accumulating radiation damage over time.After ground command initiation, all the fluidics, thermal and optical detection steps in BioSentinel are fully automated.The biosensor response data is compared to physical dosimetry data collected onboard the same payload. This dosimeter or linear energy transfer (LET)spectrometer is based on TimePix chip technology. This chip measures the total ionizing radiation dose in addition to calculating the LET of each particle that traverses its sensor, thus allowing researchers to characterize the radiation environment around the payload.The biological response (and physical dosimetry) on ISS over time is compared to the deep space mission and to data obtained on the ground.This analysis provides insight on the biological effects of the space radiation exposure in preparation for future long-duration missions to space and inhabitation beyond low-Earth orbit (LEO).

BioSentinel↗